So far, two immune checkpoint blockades, cytotoxic T lymphocyte-associated 4 molecule (CTLA-4) and programmed death 1 (PD-1) have been intensively studied in the treatment of metastatic melanoma. The gene discussed is PDCD1; the disease is metastatic melanoma.